Skip to main content

Animations

Illustrated close up of DNA.

Research Tools Catalog

To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.

Helpful Resources

  • Illustrated adjacent hexagons.

    Sponsored Tools Program

    Learn more about how MJFF can help share your tools.

  • Illustrated Parkinson's Disease Research Tools Consortium logo.

    Tools Consortium

    MJFF is working with industry to develop priority tools.

  • Illustrated brain on a presentation display.

    Preclinical Models

    Learn more about the various in vivo models used in Parkinson's disease research.

Find a Research Tool

Filter by Tool Type or Gene/Protein Type to Organize Results

* = MJFF does not control pricing or terms of availability for this tool. 

Filters
Sort options
Sort by
Order
Filters
Sort options
Sort by
Order
Sort options
Sort by
Order
Results (277)
Sort by:
p62 pT138 Phosphospecific Antibody
Antibody
Rabbit monoclonal phosphospecific antibody directed against Threonine 138 of the p62 protein. Suitable for immunoblotting applications.
  • p62
LEGEND MAX™ Human Alpha-Synuclein ELISA Kit*
Assay
ELISA kit developed in collaboration with Covance for measuring human alpha-synuclein protein in biological samples. The assay has been demonstrated to conform to AAPS performance criteria using CSF as a matrix. Please note, this assay was previously made available as an ECL ELISA but has since switched to Colorimetric. 
  • Alpha-Synuclein
Alpha-Synuclein 1-122 Truncation Antibody
Antibody
Rabbit monoclonal antibody directed against alpha-synuclein truncated at the 122 residue.  Estimated Availability: Early 2025
  • Alpha-Synuclein
Alpha-Synuclein 1-119 Truncation Antibody
Antibody
Rabbit monoclonal antibody directed against alpha-synuclein truncated at the 119 residue.  Estimated Availability: Early 2025
  • Alpha-Synuclein
Human Parkin Mouse*
Mouse Model
Transgenic mice expressing wild type human Parkin under the direction of the mouse prion protein promoter. Model was generated and deposited by Konstanze Winklhofer at Ruhr University Bochum through the MJFF Sponsored Tools Program (available through cryorecovery). RRID:IMSR_JAX:027630 
  • Parkin
Alpha-Synuclein Antibody
Antibody
Mouse anti-alpha-synuclein antibody that has undergone Fc species switching to develop mouse reagents from the original rabbit antibody (MJFR1). The new chimeric antibody is approved for immunoblotting and immunohistochemistry and can be detected using Fc-specific secondary antibodies to mouse IgG.
  • Alpha-Synuclein
ATP13A2 Knockout Mouse*
Mouse Model
Mice carrying a Atp13a2 mutation resulting in disruption of exons 12 through 15 and a portion of exon 16. Model was generated and deposited by Patrick Schultheis at Northern Kentucky University through the MJFF Sponsored Tools Program (available through cryorecovery). RRID:IMSR_JAX:021914
  • ATP13A2
Alpha-Synuclein Ubiquitinated at K45/48/60 Antibody
Antibody
Rabbit monoclonal antibody directed against the K45/48/60-ubiquitinated alpha-synuclein.  Estimated Availability: Late 2025
  • Alpha-Synuclein
GBA E326K Knockin Mouse*
Mouse Model
Mouse expressing GBA E326K mutation and 3 silent mutations in exon 8 of the mouse Gba gene. Model was generated and deposited by Mark Cookson at NIH through the MJFF Sponsored Tools Program. RRID:IMSR_JAX:036159
  • GBA
TMEM192 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM192 for immunoprecipitation of endogenous lysosomes. Estimated Availability: Late 2025
  • TMEM192
Have questions or need additional information?

Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page. 

"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD Mayo Clinic
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.